Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-26,100
Closed -$611K 4177
2025
Q3
$611K Buy
+26,100
New +$524K ﹤0.01% 1778
2025
Q2
Sell
-12,500
Closed -$259K 3651
2025
Q1
$259K Buy
+12,500
New +$225K ﹤0.01% 1854
2023
Q4
Sell
-20,500
Closed -$376K 3187
2023
Q3
$376K Sell
20,500
-7,200
-26% -$122K ﹤0.01% 1561
2023
Q2
$371K Buy
+27,700
New +$273K ﹤0.01% 1508
2023
Q1
Sell
-49,400
Closed -$491K 3295
2022
Q4
$491K Buy
49,400
+1,900
+4% +$17.1K 0.01% 1441
2022
Q3
$567K Buy
+47,500
New +$1.02M 0.01% 1353
2021
Q4
Sell
-6,200
Closed -$220K 4210
2021
Q3
$220K Sell
6,200
-5,400
-47% -$214K ﹤0.01% 2622
2021
Q2
$515K Sell
11,600
-31,100
-73% -$1.06M ﹤0.01% 1740
2021
Q1
$1.56M Sell
42,700
-1,300
-3% -$54K 0.02% 763
2020
Q4
$1.88M Buy
+44,000
New +$1.62M 0.04% 344

Other funds holding XPEV

HRT Financial's XPEV Position: Q4 2025 in Review

HRT Financial sold out of XPeng (XPEV) in Q4 2025, closing a stake of 189,946 shares — an estimated $4.45M sold.

HRT Financial first reported a position in XPEV in Q1 2021 and held it in 11 quarters. The position peaked at $15.6M in Q3 2023. 240 funds tracked by Wall St. Rank hold XPEV as of Q4 2025.

  • HRT Financial reported no remaining XPeng position as of Q4 2025 after selling out during the quarter.
  • HRT Financial sold 189,946 XPeng shares in Q4 2025, an estimated $4.45M.
  • HRT Financial first reported a position in XPeng in Q1 2021 and held it in 11 quarters.
  • HRT Financial's XPeng position peaked at $15.6M in Q3 2023.
  • 240 funds tracked by Wall St. Rank held XPeng as of Q4 2025.

Based on HRT Financial's 13F filing for Q4 2025, filed 12 Feb 2026.